Pharma-Bio Serv (PBSV) Non-Current Assets (2010 - 2026)

Pharma-Bio Serv's Non-Current Assets history runs 16 years deep, the most recent figure standing at $213126.0 for Q2 2026.

• Non-Current Assets for Q2 2026 came in at $213126.0, down 56.16% year-over-year; the trailing twelve-month figure through Apr 2026 was $1.1 million (down 43.46% YoY), and the FY2025 annual result was $266201.0, down 55.15% from the prior year.
• Non-Current Assets came in at $213126.0 for Q2 2026 at Pharma-Bio Serv, down from $224457.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $2.7 million in Q1 2023 to a low of $213126.0 in Q2 2026.
• A 5-year average of $659288.3 and a median of $521787.5 in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 153.05% in 2023 and tumbled 82.87% in 2024, its largest moves.
• Over 5 years, Non-Current Assets stood at $707243.0 in 2022, then retreated by 29.17% to $500964.0 in 2023, then rose by 18.47% to $593477.0 in 2024, then sank by 55.15% to $266201.0 in 2025, then fell by 19.94% to $213126.0 in 2026.
• The last three Non-Current Assets figures came in at $213126.0 (Q2 2026), $224457.0 (Q1 2026), and $266201.0 (Q4 2025), per Business Quant data.